Valuation: AtriCure, Inc.

Market Cap 300.72Cr 262.23Cr 247.61Cr 224.84Cr 421.27Cr 29TCr 423.02Cr 2.97TCr 1.14TCr 15TCr 1.13TCr 1.1TCr 47TCr P/E 2026 *
560x
P/E 2027 * 141x
Enterprise Value 285.51Cr 248.96Cr 235.08Cr 213.47Cr 399.96Cr 27TCr 401.63Cr 2.82TCr 1.09TCr 14TCr 1.07TCr 1.05TCr 45TCr EV / Sales 2026 *
4.71x
EV / Sales 2027 * 4.09x
Free-Float
96.23%
Yield 2026 *
-
Yield 2027 * -
1 day+0.34%
1 week+8.80%
Current month+22.73%
1 month+29.68%
3 months+106.04%
6 months+105.68%
Current year+50.00%
1 week 54.65
Extreme 54.65
59.88
1 month 46.28
Extreme 46.28
59.88
Current year 25.36
Extreme 25.36
59.88
1 year 25.36
Extreme 25.36
59.88
3 years 18.94
Extreme 18.94
59.88
5 years 18.94
Extreme 18.94
89.18
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 59 18/07/2017
Director TitleAgeSince
Director/Board Member 55 02/11/2012
Director/Board Member 64 11/03/2013
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
11/09/26 Sell

Director

-5,313 0.0104%
08/09/26 Sell

Chief Technology Officer

-3,657 0.0072%
02/09/26 Sell

Chief Technology Officer

-7,763 0.0153%
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%+8.80%+61.87%+36.54% 300.72Cr
+0.87%+0.53%-23.84%+1.48% 18TCr
-0.31%+1.66%-3.26%+11.68% 12TCr
+0.62%-3.61%+6.57%+73.13% 5.9TCr
+0.39%+1.51%-4.16%-31.76% 4.94TCr
-0.22%-2.29%+5.98%+35.20% 4.86TCr
+2.09%+7.53%+17.81%-6.31% 3.32TCr
-0.75%-1.97% - - 2.82TCr
-1.59%+3.90%+41.09%-8.83% 2.58TCr
+1.02%+6.33%+11.64%-21.98% 2.19TCr
Average +0.20%+2.20%+12.63%+9.90% 5.65TCr
Weighted average by Cap. +0.30%+0.73%-3.80%+9.88%

Financials

2026 *2027 *
Net sales 61Cr 53Cr 50Cr 45Cr 85Cr 5.82TCr 85Cr 597.91Cr 230.73Cr 2.96TCr 227.73Cr 222.67Cr 9.52TCr 68Cr 59Cr 56Cr 51Cr 95Cr 6.52TCr 96Cr 670.38Cr 258.7Cr 3.32TCr 255.33Cr 249.66Cr 11TCr
Net income 71.12L 62.02L 58.56L 53.18L 99.63L 68Cr 1Cr 7.01Cr 2.71Cr 35Cr 2.67Cr 2.61Cr 111.64Cr 2.08Cr 1.81Cr 1.71Cr 1.55Cr 2.91Cr 199.36Cr 2.92Cr 20Cr 7.91Cr 101.36Cr 7.8Cr 7.63Cr 326.13Cr
Net Debt -15Cr -13Cr -13Cr -11Cr -21Cr -1.46TCr -21Cr -150.03Cr -58Cr -742.09Cr -57Cr -56Cr -2.39TCr -23Cr -20Cr -19Cr -17Cr -32Cr -2.17TCr -32Cr -223.19Cr -86Cr -1.1TCr -85Cr -83Cr -3.55TCr
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
19/26/19 $59.33 +0.36% 11,16,997
17/26/17 $59.12 +3.47% 15,39,652
16/26/16 $57.14 +1.64% 12,16,889
15/26/15 $56.22 +0.77% 14,32,311
14/26/14 $55.79 +2.29% 11,54,697
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
59.12USD
Average target price
53.33USD
Spread / Average Target
-9.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!